BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30371579)

  • 1. Primary and Secondary Breast Angiosarcoma: FDG PET/CT Series.
    Cassou-Mounat T; Champion L; Bozec L; Laurence V; Huchet V; Luporsi M; Jehanno N
    Clin Nucl Med; 2019 Jan; 44(1):e33-e35. PubMed ID: 30371579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of
    Umemura H; Yamasaki O; Kaji T; Hamada T; Otsuka M; Asagoe K; Iwatsuki K
    J Dermatol; 2017 Sep; 44(9):1046-1049. PubMed ID: 28370268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [18F-FDG PET/CT contributes to diagnostics and therapy monitoring of radiation-induced angiosarcoma].
    Cucchi F; Bülow J; Simonsen L; Nedergaard L; Haarmark C; Asmar A
    Ugeskr Laeger; 2017 Jan; 179(1):. PubMed ID: 28074770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone metastases with "false negative" findings on 18F-FDG PET/CT in patients with angiosarcoma: A case series with literature review.
    Ariga A; Matsumoto S; Tanizawa T; Hayakawa K; Minami Y; Saito M; Kurosawa N; Yamashita K; Terauchi T; Ae K
    Medicine (Baltimore); 2023 Jul; 102(28):e34196. PubMed ID: 37443509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of SUV
    Diao W; Tian F; Jia Z
    Eur J Radiol; 2018 Aug; 105():1-7. PubMed ID: 30017264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive FAPI PET/CT in a Bilateral Mammary Angiosarcoma Patient With Less Impressive FDG PET/CT Images.
    Qiu S; Zou S; Cheng S; Song S; Zhu X
    Clin Nucl Med; 2022 Jul; 47(7):648-650. PubMed ID: 35143460
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Mestres-Marti J; Llinares-Tello E; Sabaté-Llobera A; Gràcia-Sánchez L; Robles-Barba J; Gámez-Cenzano C
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(3):183-185. PubMed ID: 30389619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers.
    Ulaner GA; Goldman DA; Gönen M; Pham H; Castillo R; Lyashchenko SK; Lewis JS; Dang C
    J Nucl Med; 2016 Sep; 57(9):1350-6. PubMed ID: 26940766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Cutaneous Angiosarcoma Mimicking Metastasis on 18F-FDG PET/CT in Woman With Cervix Cancer.
    Hwang JP
    Clin Nucl Med; 2017 Sep; 42(9):e415-e416. PubMed ID: 28632698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of the SUVmax of FDG-PET and ADC values of diffusion-weighted MR imaging with pathologic prognostic factors in breast carcinoma.
    Kitajima K; Yamano T; Fukushima K; Miyoshi Y; Hirota S; Kawanaka Y; Miya M; Doi H; Yamakado K; Hirota S
    Eur J Radiol; 2016 May; 85(5):943-9. PubMed ID: 27130054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Common Iliac Artery Angiosarcoma With Multiple Bone Metastases Revealed by Dual-Time Point FDG PET/CT Imaging.
    Wang R; Wang X; Ji B; Guan Q; Chen B
    Clin Nucl Med; 2019 Mar; 44(3):232-233. PubMed ID: 30624266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic Angiosarcoma With Diffuse Increased 18 F-FDG Uptake on PET/CT.
    Zhou Z; Lu X; Wang W; Yang J
    Clin Nucl Med; 2022 Sep; 47(9):817-819. PubMed ID: 35383600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of 18F-FDG PET/CT in evaluating molecular subtypes and clinicopathological features of primary breast cancer.
    Arslan E; Çermik TF; Trabulus FDC; Talu ECK; Başaran Ş
    Nucl Med Commun; 2018 Jul; 39(7):680-690. PubMed ID: 29893750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG PET/CT of Cardiac Angiosarcoma With Pulmonary Metastases.
    Hod N; Shalev A; Levin D; Anconina R; Ezroh Kazap D; Lantsberg S
    Clin Nucl Med; 2018 Oct; 43(10):744-746. PubMed ID: 30036249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. F-18 fluorodeoxyglucose PET/CT as an imaging tool for staging and restaging cutaneous angiosarcoma of the scalp.
    Vasanawala MS; Wang Y; Quon A; Gambhir SS
    Clin Nucl Med; 2006 Sep; 31(9):534-7. PubMed ID: 16921276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG PET/CT in Primary Splenic Angiosarcoma With Diffuse Involvement of the Spleen.
    Zhao Q; Dong A; Wang Y; He T; Zuo C
    Clin Nucl Med; 2017 Oct; 42(10):815-817. PubMed ID: 28806241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Pulmonary Low-Grade Angiosarcoma Characterized by Mismatch between ¹⁸F-FDG PET and Dynamic Contrast-Enhanced CT.
    Kim EY; Lee HY; Han J; Choi JY
    Korean J Radiol; 2015; 16(5):1166-70. PubMed ID: 26357507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A low-grade bone angiosarcoma presented as low to mild
    Li F; Ou X
    Hell J Nucl Med; 2020; 23(3):360-361. PubMed ID: 33306768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast angiosarcoma: FDG PET findings.
    Zeng W; Styblo TM; Li S; Sepulveda JN; Schuster DM
    Clin Nucl Med; 2009 Jul; 34(7):443-5. PubMed ID: 19542952
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
    Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
    Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.